Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
2010-01-15
A single sub-anesthetic (intravenous) IV dose of ketamine might have rapid but transient antidepressant effects in patients with treatment-resistant depression (TRD). Here we tested the tolerability, safety, and efficacy of repeated-dose open-label IV ketamine (six infusions over 12 days) in 10 medication-free symptomatic patients with TRD who had previously shown a meaningful antidepressant response to a single dose.Read More →